Public Policy

Attorney Everett Wilson, managing partner at Polsinelli's Miami office, discusses overall changes in Medicare and Medicare Advantage - and how the recent benefits changes affect consumers, payers and plans.

Donald Rucker, chief strategy officer at 1upHealth, discusses the details associated with CMS' Medicare Star Ratings, balancing the complexity and interest of patients and taxpayers, and what plans need to do to up their rating.

Jenn Kerfoot, chief strategy and growth officer at DUOS, discusses why only seven plans made five stars for Medicare Advantage Star Ratings, as opposed to 30 the previous year, and how plans can ensure a positive rating in the future.

The Agency says AI can transform multiple aspects of healthcare, but it is difficult to fully oversee and regulate the technology without the assistance of all sectors involved.

The algorithms are used to detect valvular heart disease.

The company is also recruiting a CEO in the US.

Jonathan French, senior director of public policy at HIMSS, says the organization hopes its members participate in the public policy development process and understand the real-world ramifications of that policy.

Also, See-Mode has received the first US FDA approval for a thyroid ultrasound analysis AI solution.

Leah Binder, president and CEO at the Leapfrog Group, discusses the finalized Patient Safety Structural Measure, which will be implemented in the government's fiscal year 2025, and how it hard-wires patient safety as a top priority in hospitals.